Study
MDS Sequencing Project Cancer Cell
| Study ID | Alternative Stable ID | Type |
|---|---|---|
| EGAS00001001011 | Other |
Study Description
Myelodysplastic syndromes (MDS) are uncommon entities, heterogeneous clinically and cytogenetically. The aim of the present study is to determine genetic alteration in this subset of patients. Expected results: Identification of new aberrations and genetic markers in order to detect novel genes involved in MDS 5q-response to Lenalidomide's treatment.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001001058 |
Cancer exome reads consisting of FASTQ paired end reads from bone marrow samples
|
Illumina HiSeq 2000 | 42 |
Who archives the data?
Publications
Citations
Retrieving...
Retrieving...
